A global epedemic

Type 2 diabetes is a global epidemic, with an estimated prevalence of 552 million in 2030. A complication of type 2 diabetes is retinopathy, increasing the risk of blindness, bearing a large impact on quality of life and high economic burden.

Screening for retinopathy is designed to detect early vision threatening changes enabling preventive treatment.

 

Screening strategies

Screening strategies in Europe range from annual to no systematic screening and follow a ‘one size fits all’ approach, ignoring the predictability of retinopathy and differences in risk between persons. With the growing prevalence of diabetes, a high disease burden and huge health care capacity problem arise when no action is taken on current inefficient screening strategy.

Therefore it is important to take action to improve retina screening in Europe on an efficient and safe way.